First Citizens Bancorporation’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$2.48M Sell
42,025
-70
-0.2% -$3.95K 1.67% 14
2014
Q3
$2.15M Sell
42,095
-1,920
-4% -$95.9K 1.56% 19
2014
Q2
$2.13M Buy
44,015
+1,365
+3% +$67.3K 1.61% 17
2014
Q1
$2.22M Sell
42,650
-1,954
-4% -$104K 1.78% 10
2013
Q4
$2.37M Sell
44,604
-906
-2% -$46.2K 1.88% 8
2013
Q3
$2.11M Buy
45,510
+955
+2% +$41.9K 1.82% 10
2013
Q2
$1.99M Buy
+44,555
New +$1.93M 1.82% 13

Other funds holding BMY

First Citizens Bancorporation's BMY Position: Q4 2014 in Review

First Citizens Bancorporation reduced its Bristol-Myers Squibb (BMY) stake by 0.17% in Q4 2014, selling an estimated $3.95K and leaving 42,025 shares worth $2.48M. The position accounts for 1.67% of the portfolio, ranked #14.

First Citizens Bancorporation first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. 1,409 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

  • First Citizens Bancorporation held 42,025 shares of Bristol-Myers Squibb worth $2.48M as of Q4 2014.
  • First Citizens Bancorporation sold 70 Bristol-Myers Squibb shares in Q4 2014, an estimated $3.95K.
  • Bristol-Myers Squibb made up 1.67% of First Citizens Bancorporation's portfolio in Q4 2014, its #14 holding.
  • First Citizens Bancorporation first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
  • 1,409 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on First Citizens Bancorporation's 13F filing for Q4 2014, filed 21 Jan 2015.